or
forgot password
  • cancer clinical trials in tucson, AZ

  • A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer
    Arizona Cancer Center - University of Arizona
    Tucson, Arizona 85724
    Carcinoma, Pancreas
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Arizona Oncology Associates D.B.A. Hematology Oncology
    Tucson, Arizona 85704
    Metastatic Breast Cancer
    A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
    Visions Clinical Research-Tucson
    Tucson, Arizona 85712
    Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia
    Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin
    Veterans Affairs Medical Center - Tucson

    Trial Locations
    Veterans Affairs Medical Center - Tucson
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Non-melanomatous Skin Cancer
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 137
    Tucson, Arizona 85710
    Hypoactive Sexual Desire Disorder
    Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Healthy, no Evidence of Disease, Non-melanomatous Skin Cancer
    A Study of Leuprolide to Treat Prostate Cancer
    Site Reference ID/Investigator# 8656
    Tucson, Arizona 85710
    Prostate Cancer
    A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
    Arizona Clinical Research Center

    Trial Locations
    Arizona Clinical Research Center
    AZ Onc Associates D.B.A. Hematology Oncology- US Oncology
    Pancreatic Neoplasms
    ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
    Arizona Oncology Associates

    Trial Locations
    Arizona Oncology Associates
    University of Arizona Cancer Center
    Non-Small Cell Lung Cancer
    Cognition in the Study of Tamoxifen and Raloxifene
    Arizona Cancer Center
    Tucson, Arizona 85724
    Cognition, Aging
    Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease
    University of Arizona / Arizona Cancer Center
    Tucson, Arizona 85724
    Symptomatic Refractory Resistant Carcinoid Disease
    Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Breast Cancer
    Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
    Investigational Site Number 840060
    Tucson, Arizona 85704
    Venous Thromboembolism, Cancer
    Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation
    Arizona Cancer Center at UMC North

    Trial Locations
    Arizona Cancer Center at UMC North
    Arizona Cancer Center at UMC North/University Medical Center
    Leukemia, Lymphoma, Hodgkin's Disease, Hematologic Neoplasms, Multiple Myeloma, Carcinoma, Renal Cell
    Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
    Arizona Oncology Associates
    Tucson, Arizona 85712-2254
    Non Small Cell Lung Cancer
    APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
    Arizona Clinical Research Center
    Tucson, Arizona 85712
    Pancreatic Cancer, Metastatic Pancreatic Cancer
    Resveratrol in Healthy Adult Participants
    Arizona Cancer Center - Tucson
    Tucson, Arizona 85724-5024
    Melanoma
    Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
    The University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Carcinoma, Transitional Cell, Bladder Cancer, Bladder Neoplasm
    Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
    Arizona Clinical Research Center
    Tucson, Arizona 85712
    Ovarian Cancer
    Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
    Arizona Cancer Center
    Tucson, Arizona 85724
    Malignant Melanoma
    Selenium in Treating Patients With Prostate Cancer
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Prostate Cancer
    A Study of IMC-A12 in Patients With Tumors Who No Longer Respond to Treatment or Who No Treatment if Available
    ImClone Investigational Site
    Tucson, Arizona 85712
    Advanced Solid Tumors
    Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
    Arizona Cancer Center
    Tucson, Arizona 85724
    Acute Myeloid Leukemia
    A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Patients With Advanced Carcinoma
    Arizona Cancer Institute, LLC
    Tucson, Arizona 85715
    Advanced Carcinoma, Non-small Cell Lung Cancer
    Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
    Arizona Cancer Center
    Tucson, Arizona 85724
    Acute Myeloid Leukemia
    Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
    Arizona Urologic Specialists
    Tucson, Arizona 85712
    Prostate Cancer
    Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
    Arizona Clinical Research Center
    Tucson, Arizona 85712
    Colorectal Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    University of Arizona Health Sciences Center

    Trial Locations
    University of Arizona Health Sciences Center
    Arizona Cancer Center at University Medical Center North
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer
    Arizona Cancer Center
    Tucson, Arizona 85724
    Ovarian Cancer
    Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Breast Cancer
    Immune Response in Peripheral Blood of Patients With Colon Cancer
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Colorectal Cancer
    Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy
    Arizona Clinical Research Center
    Tucson, Arizona 85712
    Cancers, Pain, Lower Back Pain
    A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
    Arizona Cancer Center
    Tucson, Arizona 85724
    Advanced or Metastatic Solid Tumors, Cancer, Solid Cancers
    Long-term Data Collection for Subjects in MDX-010 Studies
    Arizona Cancer Center
    Tucson, Arizona 85724
    Metastatic Melanoma
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma
    Arizona Clinical Research Center
    Tucson, Arizona 85712
    Melanoma
    Limonene Study in Women With Breast Cancer
    Arizona Cancer Center
    Tucson, Arizona 85724
    Breast Cancer
    SciBase International Melanoma Pivotal Study
    University of Arizona
    Tucson, Arizona 85724
    Malignant Melanoma
    Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice
    Arizona Cancer Center
    Tucson, Arizona 85724
    Breast Cancer
    A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer
    Arizona Clinical Research Center
    Tucson, Arizona 85712
    Metastatic Pancreatic Cancer
    Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy
    Arizona Cancer Center
    Tucson, Arizona 85724
    Breast Neoplasms, Breast Diseases
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    Arizona Urologic Specialists
    Tucson, Arizona 85712
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium
    Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma
    Arizona Cancer Center at University of Arizona
    Tucson, Arizona 85724
    Metastatic Pancreatic Adenocarcinoma
    Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
    Arizona Cancer Center
    Tucson, Arizona 85724
    Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Primary Peritoneal Neoplasm
    Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
    Desert Sun Clinical Research, LLC
    Tucson, Arizona 85710
    Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer
    Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors
    Site Reference ID/Investigator# 49953
    Tucson, Arizona 85724-5024
    Advanced Solid Tumors